Aethlon Medical, Inc. (NASDAQ: AEMD) related to its merger with North Immunology, Inc. Upon closing of the proposed transaction, Aethlon shareholders will own approximately 4.75% of the combined company.
Aethlon Medical, Inc. (NASDAQ: AEMD) related to its merger with North Immunology, Inc. Upon closing of the proposed transaction, Aethlon shareholders will own approximately 4.75% of the combined company.